Surgery Partners, Inc. (NASDAQ:SGRY) Stock Position Boosted by First Eagle Investment Management LLC

First Eagle Investment Management LLC boosted its position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 47.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 291,374 shares of the company's stock after purchasing an additional 94,243 shares during the quarter. First Eagle Investment Management LLC owned about 0.23% of Surgery Partners worth $9,321,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Wellington Management Group LLP lifted its position in shares of Surgery Partners by 23.2% during the 3rd quarter. Wellington Management Group LLP now owns 8,022,700 shares of the company's stock valued at $234,664,000 after acquiring an additional 1,511,396 shares during the period. Deerfield Management Company L.P. Series C acquired a new position in shares of Surgery Partners during the 3rd quarter worth $42,705,000. Invesco Ltd. raised its holdings in shares of Surgery Partners by 9.3% during the 3rd quarter. Invesco Ltd. now owns 3,604,357 shares of the company's stock worth $105,427,000 after buying an additional 305,216 shares in the last quarter. Barclays PLC increased its holdings in Surgery Partners by 204.9% in the 3rd quarter. Barclays PLC now owns 289,663 shares of the company's stock worth $8,472,000 after purchasing an additional 194,658 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC increased its holdings in Surgery Partners by 26,274.7% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 187,788 shares of the company's stock worth $5,493,000 after purchasing an additional 187,076 shares in the last quarter.

Surgery Partners Stock Performance

NASDAQ:SGRY traded down $0.62 during trading hours on Friday, reaching $25.83. The stock had a trading volume of 781,405 shares, compared to its average volume of 1,096,034. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.56 and a current ratio of 1.71. The stock has a 50 day simple moving average of $26.82 and a 200 day simple moving average of $30.01. Surgery Partners, Inc. has a 12-month low of $22.05 and a 12-month high of $45.79. The stock has a market cap of $3.28 billion, a P/E ratio of 30.76, a price-to-earnings-growth ratio of 2.04 and a beta of 2.75.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings results on Monday, February 26th. The company reported $0.44 EPS for the quarter, topping analysts' consensus estimates of $0.37 by $0.07. Surgery Partners had a return on equity of 3.65% and a net margin of 0.02%. The firm had revenue of $735.40 million during the quarter, compared to analyst estimates of $741.93 million. During the same period last year, the company earned $0.22 earnings per share. The business's revenue for the quarter was up 4.0% on a year-over-year basis. On average, research analysts forecast that Surgery Partners, Inc. will post 0.84 EPS for the current fiscal year.

Insider Transactions at Surgery Partners

In related news, CEO Jason Eric Evans sold 4,840 shares of Surgery Partners stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $29.71, for a total transaction of $143,796.40. Following the completion of the sale, the chief executive officer now owns 459,670 shares of the company's stock, valued at $13,656,795.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 2.60% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $49.00 target price on shares of Surgery Partners in a report on Thursday, February 29th. Benchmark reissued a "buy" rating and issued a $50.00 price target on shares of Surgery Partners in a research note on Wednesday, May 1st. Cantor Fitzgerald reissued an "overweight" rating and issued a $43.00 price target on shares of Surgery Partners in a research note on Wednesday, April 10th. Barclays initiated coverage on Surgery Partners in a research report on Wednesday, March 6th. They set an "equal weight" rating and a $35.00 target price on the stock. Finally, Citigroup cut their price target on Surgery Partners from $42.00 to $38.00 and set a "buy" rating on the stock in a report on Wednesday, May 8th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $43.13.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.